Predispensing of antivirals to high-risk individuals in an influenza pandemic

PLoS Currents

Volumn , Issue AUG, 2009, Pages

  Goldstein, Edward ^a   Miller, Joel C ^b   O'Hagan, Justin ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79957708581     PISSN: None     EISSN: 21573999     Source Type: Journal    
DOI: 10.1371/currents.RRN1007     Document Type: Article

References (29)

1. Aoki FY, Macleod MD, Paggiaro P, Carewicz O, El Sawy A, Wat C, Griffiths M, Waalberg E, Ward P, IMPACT Study Group: Early administration of oral oseltamivir increases the benefits of influenza treatment. J Antimicrob. Chemother. 2003; 51(1) 123-9
2. Burch J, Corbett M, Stock C, Nicholson K, Elliot AJ, Duffy S, Westwood M, Palmer S, Stewart L: Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis. Lancet Infect Dis. 2009 Aug 7. [Epub ahead of print] PubMed PMID: 19665930
3. McClellan K, Perry CM, Oseltamivir: a review of its use in influenza. Drugs. 2001;61(2):263-83.
4. Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med. 2003 Jul 28;163(14):1667-72.
5. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al. Hospitalized Patients with 2009 H1N1 Influenza in the United States, April-June 2009. N Engl J Med 2009 Oct 8.
6. Janice K. Louie; Meileen Acosta; Kathleen Winter; et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA. 2009;302(17):1896-1902 (doi:10.1001/jama.2009.1583)
7. CNN. Oct. 13, 2009 Study: Underlying conditions playing less of role in H1N1 http://www.cnn.com/2009/HEALTH/10/13/h1n1.preexisting.conditions/index.html
8. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009 Aug 8;374(9688):451-8. Ministerio de Salud, Chile. Influenza pandemica (H1N1) 2009. REPORTE 21 DE OCTUBRE DE http://www.redsalud.gov.cl/minsalaudios/reporte22octubre.pdf
9. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quinones-Falconi F, Bautista E, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med2009 Aug 13;361(7):680-9.
10. Rello J, Rodriguez A, Ibanez P, Socias L, Cebrian J, Marques A, et al. Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain. Crit Care2009 Sep 11;13(5):R148
11. H1N1 leading to increased flu rates, more pediatric deaths. http://www.rwjf.org/publichealth/digest.jsp?id=23828
12. CDC. Updated Interim Recommendations for the Use of Antiviral Medications in the Treatment and Prevention of Influenza for the 2009-2010 Season. http://www.cdc.gov/h1n1flu/recommendations.htm
13. Public Health Agency of Canada. Use of antivirals to treat H1N1 flu virus. http://www.phac-aspc.gc.ca/alertalerte/h1n1/antiviral-antiviraux05-01-eng.php
14. Ministère chargée de la santé. Prise en charge d'un cas de grippe A(H1N1) chez un adulte ou un enfant de plus de 40 kg. Grippe, formation, information, communication. Fiche mémo; 2009; http://www.santesports. gouv.fr/IMG//pdf/Prise_en_charge_d_un_cas_de_grippe_A_H1N1_chez_un_adulte_ou_un_enfant_de_plus_de_40_kg.16. Department of Health and Ageing, Australia. Antiviral medication use-treatment. http://www.healthemergency.gov.au/internet/healthemergency/publishing.nsf/Content/clinical-antiviral
15. National Health Coordination Center, New Zealand. Guidance on the diagnosis and management of Pandemic (H1N1) 2009 in the Pandemic 'Management' phase, Version 3. http://www.moh.govt.nz/moh.nsf/pagesmh/9171/$File/diagnosis-and-mgmt-guidance-for-mgmt-phase-v3-30july09.doc
16. MIDAS High Risk Segmentation Group. (D. Wagener, private communication, 2009).
17. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006; 295(13):1549-1555.
18. CDC. A weekly influenza surveillance report prepared by the influenza division. http://www.cdc.gov/flu/weekly/
19. Keren R, Zaoutis TE, Bridges CB, et al. Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. JAMA 2005;294:2188-2194
20. Toovey S, Rayner C, Prinssen E, Chu T, Donner B, Thakrar B, Dutkowski R, Hoffmann G, Breidenbach A, Lindemann L, Carey E, Boak L, Gieschke R, Sacks S, Solsky J, Small I, Reddy D. Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review. Drug Saf. 2008;31(12):1097-114. doi: 10.2165/0002018-200831120-00006. Review. PubMed PMID: 19026027
21. Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis. 2002 Apr;8(4):347-54.
22. Weekly pandemic flu media update. Health Protection Agency. 22 October 2009 http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1254510639308
23. Lipsitch M, Cohen T, Murray M, Levin BR (2007) Antiviral Resistance and the Control of Pandemic Influenza. PLoS Med 4(1): e15. http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.0040015
24. Wu JT, Leung GM, Lipsitch M, Cooper BS, Riley S (2009) Hedging against Antiviral Resistance during the Next Influenza Pandemic Using Small Stockpiles of an Alternative Chemotherapy. PLoS Med 6(5): e1000085. http://www.plosmedicine.org/article/info:doi%2F10.1371%2Fjournal.pmed.1000085
25. Presanis AM, Lipsitch M, DeAngelis D et. al. The severity of pandemic H1N1 influenza in the United States, April-July 2009 http://knol.google.com/k/anne-m-presanis/the-severity-of-pandemic-h1n1-influenza/agr0htar1u6r/16#
26. Washington Post. Oct 2, 2009. CDC Reports 28 Flu Deaths Among Pregnant Women. http://www.washingtonpost.com/wp-dyn/content/article/2009/10/01/AR2009100104308.html
27. Swine flu poses risks to kids with neurological conditions. Medline Plus, Sep. 3, 2009 http://www.nlm.nih.gov/medlineplus/news/fullstory_88952.html
28. E. Goldstein, M. Lipsitch. Antiviral usage for H1N1 treatment: pros, cons, and an argument for broader prescribing guidelines in the United States. PLOS Currents Influenza. http://knol.google.com/k/edwardgoldstein/antiviral-usage-for-h1n1-treatment-pros/1dfgb8wq76hv/2#
29. Goldstein E, Cowling B, O'Hagan J, Danon L, Fang V, Hagy A, Miller JC, Reshef D, Robins J, Biedrzycki P, Lipsitch M. Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009, Submitted. http://www.plosmedicine.org/article/info:doi%2F10.1371%2Fjournal.pmed.1000085